Sarah Londrigan

21PUBLICATIONS
100CO-AUTHORS
Animal protection (incl. pests and pathogens)Proteins and peptidesGene and molecular therapyInnate immunityIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 28, 2026
Bovine myxovirus resistance protein (Mx)1, but not Mx2, mediates antiviral activity against human and avian influenza A viruses, including H5N1 clade 2.3.4.4b.

|Sep 15, 2025
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.

Rubaiyea Farrukee, Francesca Mordant, Charley Mackenzie-Kludas

|Jun 28, 2023
TRIM16 Overexpression in HEK293T Cells Results in Cell Line-Specific Antiviral Activity.

Lance R Nigos, Nichollas E Scott, Andrew G Brooks

|May 15, 2023
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity.

Elise Gressier, Jonas Schulte-Schrepping, Lev Petrov

|Apr 28, 2023
Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity.

Tina Meischel, Svenja Fritzlar, Fernando Villalón-Letelier

|Apr 25, 2023
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release.

Larisa I Labzin, Keng Yih Chew, Kathrin Eschke

Pageof 4

Frequent Collaborators

12 joint publications

Patrick C Reading

3 joint publications

Katherine Kedzierska

3 joint publications

Gregory Moseley

3 joint publications

Thomas M Ashhurst